Search
Filter Results
Displaying 351–360 of 723 for “Visions 2020”
-
Jun 12, 2012
Could Combining Future Treatments Be an Option?
How therapies will likely be used synergistically in the future.
-
May 24, 2021
Girl Scouts are Changing the World One Crosswalk at a Time
Inspired by their troop leader diagnosed with Usher syndrome, Girl Scout Troop 1673 is hoping to change the world, one crosswalk at a time, with their Paint It Yellow challenge.
-
Sep 18, 2023
How an Assistive App Developer is Revolutionizing Accessibility
Meet Rebecca Rosenberg, the founder of ReBokeh Vision Technologies, whose journey from engineer to entrepreneur may have been guided by fate. Diagnosed with oculocutaneous albinism (OCA1) at a young age, Rebecca faced numerous obstacles due to the lack of assistive technology tailored to her unique needs. This inspired her to create an app that would revolutionize the world of assistive technology for those with moderate low vision.
-
Dec 12, 2022
Resourceful Advocate for Research
Manorthia was diagnosed with retinitis pigmentosa (RP) when she was 22 years old but didn’t start experiencing considerable vision loss until years later. Once she began to notice her vision deteriorating more rapidly, she reached out to the Foundation Fighting Blindness to get involved with the blindness community.
-
May 2, 2024
Atsena’s XLRS Gene Therapy Shows Efficacy in Phase 1/2 Clinical Trial
The XLRS gene therapy was well tolerated and resolved damaging schisis cavities in patients receiving the lowest dose.
-
Apr 30, 2024
Usher Syndrome Research Advances
Recent developments in research on Usher Syndrome.
-
Apr 11, 2024
ViGeneron Launches Clinical Trial of Gene Therapy for RP Caused by CNGA1 Mutations
The gene therapy is administered using a less-invasive intravitreal injection.
-
Mar 25, 2024
Collaboration will add a new multi-gene cohort of patients living with inherited retinal diseases. Data insights from the new study cohort will inform the future clinical trial design for BlueRock’s pipeline of cell therapies for treating blindness.
-
Feb 15, 2024
The May 9th gala will raise awareness and fund research leading to treatments and cures for blinding retinal diseases.
-
Dec 11, 2023
Known as antisense oligonucleotides, the treatments performed encouragingly in ProQR’s clinical trials